Category & trade
Primary
pharmaceutical-drugs · embed-ft 0.5
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Also (top-3)
cancer0.21
Tech stack
CMS
Analytics
CDN
Framework
Consent/CMP
AI readiness
AI-Readiness score
34 / 100 · partial · see similar
AI training policy
allowed
Terms of Service
AI-bot protection
AI files
Compliance (GEO / GDPR)
TLD
Overview
Title
ROS1+ Non-Small Cell Lung Cancer & NTRK+ Cancer Treatment | AUGTYRO® (repotrectinib)
Description
AUGTYRO® (repotrectinib) is an oral medicine for ROS1+ non-small cell lung cancer and NTRK+ cancer. Speak with your physician to learn more.
Final URL
Language
en (html)
Scanned at
2026-06-19 02:30:03